Pertussis vaccine acellular with diphtheria and tetanus toxoids, adsorbed
Brand: Adacel®
PBAC's latest decision on Pertussis vaccine acellular with diphtheria and tetanus toxoids, adsorbed: Recommended with restriction (2006). Considered for active immunisation against tetanus, diphtheria and pertussis in persons aged 10 years and over as a booster following primary immunisation.
PBAC outcome
Recommended with restriction
Unrestricted
ICER (AUD/QALY)
Cost-min
cost-minimisation analysis
Submissions
1
first 2006
Submissions
1
2006 → 2006
Eligible population
adolescents aged 10 years and over
Therapy area
Immunology
Line of therapy
Later-line
Evidence base
RCT, Single-arm
Primary endpoint
Surrogate
Key trials
Southern et al (2005), Pichichero et al, Greco et al (1996)
Comparator
Boostrix
Economic model
Cost-minimisation
ICER note
Cost-minimisation analysis performed; no ICER calculated as claimed equi-effectiveness